Postmarketing Surveillance Study for Kyprolis® (carfilzomib) in Korea (20160117)

First published 30/06/2017

Last updated 27/03/2024

EU PAS number:

EUPAS18108

Study

Ongoing

Download as PDF

Documents

Study protocol

Initial protocol

01 20 01 Protocol Ver 1 0 2016-03-29 English (002)

English (717.33 KB - PDF)View document

Study results

Study results

20160117 abstract ORSR_Redacted

English (172.51 KB - PDF)View document

Study report

Other information